Health Care & Life Sciences » Pharmaceuticals | Pharmally International Holding Co. Ltd.

Pharmally International Holding Co. Ltd.

Pharmally International Holding Co. Ltd.
Stock Exchange Taiwan Stock Exchange
EPS
TWD14.61
Market Cap
TWD18.1 T
Shares Outstanding
78 M
Public Float
45.19 M

Profile

Address
18th Floor
Taipei TP 11012
Taiwan
Employees -
Website http://www.pharmally.com
Updated 07/08/2019
Pharmally International Holding Co., Ltd. engages in the manufacture and sale of infusion and active pharmaceutical ingredient (API) products. It focuses on basic infusion, infusion therapy, and API. Its products include glucose, sodium chloride, glucose & sodium chloride, compound sodium chloride, lactated ringer's, dextran 40 glucose, dextran 20 glucose, ambroxol hydrochloride & glucose, levofloxacin lactate & sodium chloride injections, nikethamide, dextran powder, and levofloxacin lactate powder.

Financials

View All
Created with Highcharts 5.0.14Pharmally International Holding Co. Ltd.Net Income. Fiscal year is January-December. All values TWD Millions.6086087667661 0301 0309039039529521 1141 114201320142015201620172018025050075010001250
Created with Highcharts 5.0.14Pharmally International Holding Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values TWD Millions.3 3593 3593 9443 9444 4104 4104 3344 3344 3054 3055 1775 17720132014201520162017201801k2k3k4k5k6k

Wen-Lai Huang
Chairman & General Manager
Tzu Yan Huang
Director